BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 14740074)

  • 1. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
    Beckman JA; Creager MA; Libby P
    JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes: one disease, multiple cardiovascular risk factors.
    Calles-Escandon J; Garcia-Rubi E; Mirza S; Mortensen A
    Coron Artery Dis; 1999; 10(1):23-30. PubMed ID: 10196684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bariatric surgery on comorbidities.
    Kaul A; Sharma J
    Surg Clin North Am; 2011 Dec; 91(6):1295-312, ix. PubMed ID: 22054155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the pharmacological regimen for patients with diabetes mellitus.
    Marso SP
    Rev Cardiovasc Med; 2004; 5(3):139-47. PubMed ID: 15346097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of insulin sensitivity in clinical practice and in research settings.
    Monzillo LU; Hamdy O
    Nutr Rev; 2003 Dec; 61(12):397-412. PubMed ID: 14968910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: issues and opportunities.
    Beckman J; Raji A; Plutzky J
    Curr Opin Cardiol; 2003 Nov; 18(6):479-85. PubMed ID: 14597889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and metabolic syndrome].
    Christ M; Klima T; Maisch B
    Herz; 2003 Dec; 28(8):674-85. PubMed ID: 14689101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: New insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease.
    Hsueh WA
    Am J Cardiol; 2003 Aug; 92(4A):1J-2J. PubMed ID: 12957320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic syndrome].
    Wirth A; Rothenfelde B
    Versicherungsmedizin; 1996 Dec; 48(6):193-9. PubMed ID: 9082643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of peroxisome proliferator-activated receptor gamma in the pathogenesis of diabetes and atheromatosis].
    Gacka M; Adamiec R; Dobosz T; Szymaniec S; Bednarska-Chabowska D
    Przegl Lek; 2004; 61(12):1436-9. PubMed ID: 15850344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
    Haffner SM
    Am J Cardiol; 2002 Oct; 90(8A):55i-61i. PubMed ID: 12419481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome and insulin resistance.
    Plosker SM
    Med Health R I; 2003 Jan; 86(1):12-5. PubMed ID: 12633015
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the adverse cardiovascular prognosis of type 2 diabetes.
    O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD
    Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease.
    Reaven GM
    Am Heart J; 1991 Apr; 121(4 Pt 2):1283-8. PubMed ID: 2008857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.